Cell Line : HS839.T
Cellosaurus Index : CVCL_0941
Cellosaurus ID : HS839.T
CCLE Name
: HS839T_FIBROBLAST
CTRP2 Name
: HS839T
Cancer Type : skin
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| HS839.T | 16-beta-bromoandrosterone | CTRP2 | 0.0011 | 37.0000 |
|
| HS839.T | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | 3-Cl-AHPC | CTRP2 | 0.0041 | 66.0000 |
|
| HS839.T | A-804598 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | AA-COCF3 | CTRP2 | 0.0010 | 8.3000 |
|
| HS839.T | ABT737 | CTRP2 | 0.0011 | 37.0000 |
|
| HS839.T | AC55649 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | Afatinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | AGK-2 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | Alisertib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HS839.T | Alpelisib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | alvocidib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | AM-580 | CTRP2 | 0.0160 | 530.0000 |
|
| HS839.T | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | ASN 05257430 | CTRP2 | 0.0011 | 37.0000 |
|
| HS839.T | AT-406 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | AT13387 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | AT7867 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | austocystin D | CTRP2 | 0.0011 | 37.0000 |
|
| HS839.T | avicin D | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | avrainvillamide | CTRP2 | 0.0020 | 33.0000 |
|
| HS839.T | Axitinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | AZ-3146 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | azacitidine | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | AZD-7545 | CTRP2 | 0.0023 | 74.0000 |
|
| HS839.T | AZD1480 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | AZD4547 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | AZD6482 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | AZD7762 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | AZD8055 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | B02 | CTRP2 | 0.0041 | 130.0000 |
|
| HS839.T | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Bax channel blocker | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | BCL-LZH-4 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Belinostat | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | bendamustine | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Bexarotene | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BI-2536 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | BIBR-1532 | CTRP2 | 0.0081 | 270.0000 |
|
| HS839.T | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BIX-01294 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BMS-195614 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BMS-345541 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BMS-536924 | CTRP2 | 0.0011 | 37.0000 |
|
| HS839.T | BMS-754807 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | Bortezomib | CTRP2 | 0.0000 | 0.1300 |
|
| HS839.T | Bosutinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| HS839.T | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HS839.T | BRD-A05715709 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | BRD-A86708339 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K02251932 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K02492147 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K03536150 | CTRP2 | 0.0081 | 270.0000 |
|
| HS839.T | BRD-K04800985 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K09587429 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K13999467 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K16147474 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K17060750 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| HS839.T | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K29313308 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K33199242 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K34222889 | CTRP2 | 0.0017 | 57.0000 |
|
| HS839.T | BRD-K35604418 | CTRP2 | 0.0081 | 270.0000 |
|
| HS839.T | BRD-K37390332 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | BRD-K41597374 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K42260513 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K48477130 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K50799972 | CTRP2 | 0.0020 | 17.0000 |
|
| HS839.T | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K51831558 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K52037352 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K55116708 | CTRP2 | 0.0020 | 17.0000 |
|
| HS839.T | BRD-K55473186 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K61166597 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K63431240 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K70511574 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K71781559 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K71935468 | CTRP2 | 0.0025 | 83.0000 |
|
| HS839.T | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K90370028 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | BRD-K92856060 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | BRD-K94991378 | CTRP2 | 0.0025 | 83.0000 |
|
| HS839.T | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-K99006945 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD-M00053801 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD1812 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD1835 | CTRP2 | 0.0041 | 130.0000 |
|
| HS839.T | BRD4132 | CTRP2 | 0.0049 | 160.0000 |
|
| HS839.T | BRD55319 | CTRP2 | 0.0011 | 37.0000 |
|
| HS839.T | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | BRD6430 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | BRD8899 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | BRD8958 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | BRD9647 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | BRD9876 | CTRP2 | 0.0041 | 130.0000 |
|
| HS839.T | brefeldin A | CTRP2 | 0.0011 | 37.0000 |
|
| HS839.T | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Cabozantinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | canertinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Carboplatin | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 47.0000 |
|
| HS839.T | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HS839.T | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | CAY10594 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | CBB-1007 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | CCT036477 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | CD-1530 | CTRP2 | 0.0041 | 130.0000 |
|
| HS839.T | CD-437 | CTRP2 | 0.0011 | 18.0000 |
|
| HS839.T | Cediranib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | cerulenin | CTRP2 | 0.0045 | 150.0000 |
|
| HS839.T | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | CHEMBL1222381 | CTRP2 | 0.0081 | 270.0000 |
|
| HS839.T | CHEMBL374350 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | CHIR-99021 | CTRP2 | 0.0024 | 80.0000 |
|
| HS839.T | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| HS839.T | CHM-1 | CTRP2 | 0.0005 | 16.0000 |
|
| HS839.T | CI-976 | CTRP2 | 0.0081 | 270.0000 |
|
| HS839.T | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | ciclosporin | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | COL-3 | CTRP2 | 0.0020 | 17.0000 |
|
| HS839.T | Compound 1541A | CTRP2 | 0.0011 | 37.0000 |
|
| HS839.T | compound 1B | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Compound 23 citrate | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | Compound 7d-cis | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | Crizotinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HS839.T | cucurbitacin I | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | curcumin | CTRP2 | 0.0051 | 170.0000 |
|
| HS839.T | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | cytochalasin B | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | Dabrafenib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Dacarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Dactolisib | CTRP2 | 0.0005 | 17.0000 |
|
| HS839.T | Daporinad | CTRP2 | 0.0001 | 2.0000 |
|
| HS839.T | Dasatinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HS839.T | dexamethasone | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | Dinaciclib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Docetaxel | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HS839.T | Doramapimod | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Doxorubicin | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HS839.T | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Entinostat | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | epigallocatechin-3-monogallate | CTRP2 | 0.0090 | 300.0000 |
|
| HS839.T | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Erlotinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | erlotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HS839.T | etomoxir | CTRP2 | 0.0090 | 300.0000 |
|
| HS839.T | Etoposide | CTRP2 | 0.0009 | 28.0000 |
|
| HS839.T | ETP-46464 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Fedratinib | CTRP2 | 0.0011 | 37.0000 |
|
| HS839.T | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| HS839.T | fluvastatin | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Foretinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | FQI-2 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| HS839.T | GANT-61 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | GDC-0879 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Gefitinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Gemcitabine | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | GMX-1778 | CTRP2 | 0.0000 | 0.3000 |
|
| HS839.T | gossypol | CTRP2 | 0.0011 | 37.0000 |
|
| HS839.T | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | GSK1059615 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | GSK2636771 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | GW-405833 | CTRP2 | 0.0041 | 130.0000 |
|
| HS839.T | GW843682X | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | HBX-41108 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | HC-067047 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | HLI 373 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | hyperforin | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | I-BET-762 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | I-BET151 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Ibrutinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | IC-87114 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Idelalisib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Imatinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | indisulam | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | isoevodiamine | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | isonicotinohydroxamic acid | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | ISOX:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| HS839.T | istradefylline | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | itraconazole | CTRP2 | 0.0005 | 17.0000 |
|
| HS839.T | IU1 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HS839.T | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 25.0000 |
|
| HS839.T | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HS839.T | JQ1 | CTRP2 | 0.0041 | 66.0000 |
|
| HS839.T | JW-480 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | JW-74 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | KH-CB19 | CTRP2 | 0.0005 | 17.0000 |
|
| HS839.T | KHS101 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Ki8751 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Ko-143 | CTRP2 | 0.0041 | 130.0000 |
|
| HS839.T | KPT185 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | KU 0060648 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | KU-55933 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | KU-60019 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | L-685458 | CTRP2 | 0.0011 | 37.0000 |
|
| HS839.T | Lapatinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | LE-135 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Linifanib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Linsitinib | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | lovastatin acid | CTRP2 | 0.0041 | 130.0000 |
|
| HS839.T | LRRK2-IN-1 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | LY-2183240 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | manumycin A | CTRP2 | 0.0009 | 30.0000 |
|
| HS839.T | marinopyrrole A | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Masitinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Merck60 | CTRP2 | 0.0010 | 17.0000 |
|
| HS839.T | Methotrexate | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | methylstat | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | MG-132 | CTRP2 | 0.0006 | 20.0000 |
|
| HS839.T | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | MI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | MI-2 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | MIRA-1 | CTRP2 | 0.0020 | 17.0000 |
|
| HS839.T | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| HS839.T | MK-0752 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | MK-1775 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | MK-2206 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | ML006 | CTRP2 | 0.0160 | 270.0000 |
|
| HS839.T | ML030 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | ML050 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | ML203 | CTRP2 | 0.0011 | 37.0000 |
|
| HS839.T | ML210 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | ML258 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| HS839.T | ML320 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | ML334 diastereomer | CTRP2 | 0.0041 | 130.0000 |
|
| HS839.T | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | MLN2480 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | myricetin | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | N9-isopropylolomoucine | CTRP2 | 0.0120 | 400.0000 |
|
| HS839.T | nakiterpiosin | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | Navitoclax | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HS839.T | necrostatin-1 | CTRP2 | 0.0160 | 530.0000 |
|
| HS839.T | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | necrosulfonamide | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Nelarabine | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | neratinib | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | Nilotinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | nintedanib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | NPC-26 | CTRP2 | 0.0012 | 40.0000 |
|
| HS839.T | NSC 74859 | CTRP2 | 0.0160 | 530.0000 |
|
| HS839.T | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | NSC632839 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | NSC95397 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | Nutlin-3a | CTRP2 | 0.0045 | 150.0000 |
|
| HS839.T | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | NVP-ADW742 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | NVP-TAE684 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | O-6-benzylguanine | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Obatoclax Mesylate | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Olaparib | CTRP2 | 0.0045 | 150.0000 |
|
| HS839.T | oligomycin A | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | omacetaxine mepesuccinate | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | OSI-027 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | OSI-930 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| HS839.T | Oxaliplatin | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | PAC-1 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | Paclitaxel | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | palmostatin B | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | pandacostat | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | parbendazole | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Parthenolide | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Pazopanib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | PD 153035 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | PDMP | CTRP2 | 0.0065 | 210.0000 |
|
| HS839.T | Pevonedistat | CTRP2 | 0.0011 | 37.0000 |
|
| HS839.T | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | PF-3758309 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | PF-4800567 hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | PF-750 | CTRP2 | 0.0081 | 270.0000 |
|
| HS839.T | PHA-793887 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | phloretin | CTRP2 | 0.0180 | 590.0000 |
|
| HS839.T | PI-103 | CTRP2 | 0.0011 | 37.0000 |
|
| HS839.T | Pictilisib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | pifithrin-alpha | CTRP2 | 0.0071 | 230.0000 |
|
| HS839.T | pifithrin-mu | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | PIK-93 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Piperlongumine | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | piperlongumine:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | pitstop2 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | PL-DI | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | pluripotin | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | PLX-4032 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | PLX-4720 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | PRIMA-1 | CTRP2 | 0.0051 | 170.0000 |
|
| HS839.T | PRL-3 Inhibitor I | CTRP2 | 0.0041 | 130.0000 |
|
| HS839.T | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | prochlorperazine | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | purmorphamine | CTRP2 | 0.0046 | 150.0000 |
|
| HS839.T | PX-12 | CTRP2 | 0.0030 | 100.0000 |
|
| HS839.T | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Quizartinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | R428 | CTRP2 | 0.0020 | 33.0000 |
|
| HS839.T | RAF265 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Rapamycin | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | Regorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Repligen 136 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | RG-108 | CTRP2 | 0.0081 | 270.0000 |
|
| HS839.T | rigosertib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | RITA | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | RO4929097 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Ruxolitinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | salermide | CTRP2 | 0.0120 | 400.0000 |
|
| HS839.T | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0066 | 220.0000 |
|
| HS839.T | Saracatinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | SB-225002 | CTRP2 | 0.0011 | 37.0000 |
|
| HS839.T | SB-431542 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | SCH-529074 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | SCH-79797 | CTRP2 | 0.0011 | 37.0000 |
|
| HS839.T | Selisistat | CTRP2 | 0.0024 | 80.0000 |
|
| HS839.T | Selumetinib | CTRP2 | 0.0081 | 270.0000 |
|
| HS839.T | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| HS839.T | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| HS839.T | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| HS839.T | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| HS839.T | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| HS839.T | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| HS839.T | selumetinib:piperlongumine (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| HS839.T | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| HS839.T | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 200.0000 |
|
| HS839.T | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 83.0000 |
|
| HS839.T | selumetinib:vorinostat (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| HS839.T | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Sepantronium bromide | CTRP2 | 0.0000 | 1.0000 |
|
| HS839.T | Serdemetan | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | sildenafil | CTRP2 | 0.0160 | 530.0000 |
|
| HS839.T | silmitasertib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | simvastatin | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| HS839.T | SJ-172550 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | skepinone-L | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | SKI-II | CTRP2 | 0.0041 | 130.0000 |
|
| HS839.T | SMER-3 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | SN-38 | CTRP2 | 0.0000 | 1.3000 |
|
| HS839.T | SNS-032 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | SNX-2112 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| HS839.T | Sorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | sotrastaurin | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | spautin-1 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Sphingosine Kinase 1 Inhibitor II | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | SR-II-138A | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | SU11274 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Sunitinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | SZ4TA2 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | T-5345967 | CTRP2 | 0.0160 | 270.0000 |
|
| HS839.T | tacedinaline | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | tacrolimus | CTRP2 | 0.0023 | 74.0000 |
|
| HS839.T | tamatinib | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | Tamoxifen | CTRP2 | 0.0030 | 100.0000 |
|
| HS839.T | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Tanespimycin | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| HS839.T | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | Telomerase Inhibitor IX | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | Temozolomide | CTRP2 | 0.0041 | 66.0000 |
|
| HS839.T | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | TGX221 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Thalidomide | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | tipifarnib-P1 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | tivantinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Tivozanib | CTRP2 | 0.0004 | 13.0000 |
|
| HS839.T | Topotecan | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | tosedostat | CTRP2 | 0.0160 | 270.0000 |
|
| HS839.T | TPCA-1 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Trametinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Tretinoin | CTRP2 | 0.0041 | 130.0000 |
|
| HS839.T | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| HS839.T | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| HS839.T | trifluoperazine | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | triptolide | CTRP2 | 0.0000 | 0.3000 |
|
| HS839.T | TW 37 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | UNC0321 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | UNC0638 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 17.0000 |
|
| HS839.T | VAF-347 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | valdecoxib | CTRP2 | 0.0180 | 600.0000 |
|
| HS839.T | vandetanib | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Veliparib | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | Venetoclax | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | VER-155008 | CTRP2 | 0.0011 | 37.0000 |
|
| HS839.T | Vincristine | CTRP2 | 0.0041 | 130.0000 |
|
| HS839.T | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | Vorinostat | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | WZ4002 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | WZ8040 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | XL765 | CTRP2 | 0.0020 | 66.0000 |
|
| HS839.T | YK-4-279 | CTRP2 | 0.0010 | 33.0000 |
|
| HS839.T | YL54 | CTRP2 | 0.0020 | 33.0000 |
|
| HS839.T | zebularine | CTRP2 | 0.0180 | 590.0000 |
|
| HS839.T | ZSTK474 | CTRP2 | 0.0020 | 66.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC